 Biomerica Inc. NASDAQ: BMRA today announced it has commenced shipping initial samples of its COVID-19 IgGIgM Rapid Test a finger prick blood test with results in 10 minutes, that can be performed by trained professionals anywhere, e.g. Evaluation test kits have been requested by Ministries of Health in multiple countries through the Companys distribution partners who are working with their government agencies to assess the tests and forecast demand. This disposable point-of-care serology test is different than the current polymerase chain reaction PCR tests in that initial studies indicate that serology tests can identify if someone has been exposed to the COVID-19 virus, and can further detect if a person was recently infected with the disease even if they have never shown or are no longer showing symptoms. 